MAGNACORT Drug Patent Profile
✉ Email this page to a colleague
When do Magnacort patents expire, and what generic alternatives are available?
Magnacort is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in MAGNACORT is hydrocortamate hydrochloride. Additional details are available on the hydrocortamate hydrochloride profile page.
Summary for MAGNACORT
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 13 |
Patent Applications: | 87 |
DailyMed Link: | MAGNACORT at DailyMed |
US Patents and Regulatory Information for MAGNACORT
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | MAGNACORT | hydrocortamate hydrochloride | OINTMENT;TOPICAL | 010554-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |